Cargando…
Exploiting Signaling Pathways and Immune Targets Beyond the Standard of Care for Ewing Sarcoma
Ewing sarcoma (ES) family of tumors includes bone and soft tissue tumors that are often characterized by a specific translocation between chromosome 11 and 22, resulting in the EWS-FLI1 fusion gene. With the advent of multi-modality treatment including cytotoxic chemotherapy, surgery, and radiation...
Autores principales: | Casey, Dana L., Lin, Tsung-Yi, Cheung, Nai-Kong V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593481/ https://www.ncbi.nlm.nih.gov/pubmed/31275859 http://dx.doi.org/10.3389/fonc.2019.00537 |
Ejemplares similares
-
MicroRNAs in Ewing Sarcoma
por: Dylla, Layne, et al.
Publicado: (2013) -
Extraosseus Ewing's Sarcoma of the Forearm
por: Bansal, Kuldeep, et al.
Publicado: (2020) -
EWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma
por: Cidre-Aranaz, Florencia, et al.
Publicado: (2015) -
Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma
por: Redini, Françoise, et al.
Publicado: (2015) -
LGR5 is Expressed by Ewing Sarcoma and Potentiates Wnt/β-Catenin Signaling
por: Scannell, Christopher A., et al.
Publicado: (2013)